40 Views | 14 Downloads
Stuart F. Quan, stuart_quan@hms.harvard.edu
Conceptualization, K.A.S., M.S., M.É.C., B.F. and R.I.L.; formal analysis, K.A.S., M.S., M.É.C., B.F., R.I.L. and S.F.Q.; data curation, M.É.C., R.L., P.G., E.T., A.A., R.I.L. and K.C.-S.; writing—original draft preparation, K.A.S., M.S., R.I.L. and S.F.Q.; writing—review and editing, M.É.C., K.C.-S., R.L., P.G., E.T., A.A., C.N.L., M.E.H., C.A.C., S.M.W.R., D.U.E., B.F., R.I.L., S.F.Q. and M.D.W. All authors have read and agreed to the published version of the manuscript.
The authors of this manuscript thank the entire staff of the Minnesota Department of Health and Los Angeles County Department of Health for their efforts in the COVID-19 response and help with the efforts required for this survey. We also thank all the people who participated in this survey for their contribution to our collective knowledge in the fight against COVID-19.
M. Czeisler reported personal fees from Vanda Pharmaceuticals Inc., research grants or gifts to Monash University from WHOOP, Inc., Hopelab, Inc., CDC Foundation, and the Centers for Disease Control and Prevention. C. Czeisler reported receiving grants and personal fees from Teva Pharma Australia, receiving grants from the National Institute of Occupational Safety and Health R01-OH-011773, personal fees from and equity interest in Vanda Pharmaceuticals Inc, educational and research support from Philips Respironics Inc, an endowed professorship provided to Harvard Medical School from Cephalon, Inc, an institutional gift from Alexandra Drane, and a patent on Actiwatch-2 and Actiwatch-Spectrum devices with royalties paid from Philips Respironics Inc. C. Czeisler’s interests were reviewed and managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies. C. Czeisler also served as a voluntary board member for the Institute for Experimental Psychiatry Research Foundation, Inc. Rajaratnam reported receiving grants and personal fees from Cooperative Research Centre for Alertness, Safety, and Productivity, receiving grants and institutional consultancy fees from Teva Pharma Australia and institutional consultancy fees from Vanda Pharmaceuticals, Circadian Therapeutics, BHP Billiton, and Herbert Smith Freehills. Quan has served as a consultant for Best Doctors, Bryte Foundation, Jazz Pharmaceuticals, and Whispersom. No other disclosures were reported.
This work was supported by the Centers for Disease Control and Prevention
M. Czeisler was supported by an Australian-American Fulbright Fellowship, with funding from The Kinghorn Foundation.
© 2022 by the authors.